Abstract / Summary
Adequate sleep supports mood regulation and injury prevention in high school female athletes; however, insufficient sleep is common in this population. Wearable devices enable continuous assessment of objective sleep metrics, but personalized feedback based on daily sleep data remains underexplored.
This study evaluated the technical and operational feasibility of a multicomponent AI-supported mobile health (mHealth) intervention that delivered personalized sleep feedback to high school female soccer players. Sleep efficiency was the primary preliminary efficacy outcome; other sleep-related measures were secondary or exploratory outcomes, and mood state and sports injury severity were exploratory outcomes.
We conducted a pilot randomized controlled trial among 25 high school female soccer players from a single team. The study briefing and system setup began on August 18, 2025, and the trial was retrospectively registered with the University Hospital Medical Information Network (UMIN) Clinical Trials Registry on April 7, 2026 (UMIN000061189). Weeks 1 to 4 constituted the baseline period. After the week 5 baseline questionnaires, participants were stratified by median baseline total sleep time (TST) and Pittsburgh Sleep Quality Index score and randomly allocated 1:1 to the intervention (n=12) or control (n=13) group. During weeks 6 to 9, the intervention group received GPT-4o-generated personalized feedback via LINE on days with valid prior-night Fitbit data, whereas the control group received daily nonpersonalized sleep information. Technical and operational feasibility outcomes included message delivery success, valid Fitbit wear nights, questionnaire completion, technical problems, adverse events, and privacy breaches. Secondary outcomes included TST, wake after sleep onset (WASO), subjective sleep quality, sleep difficulty, and daytime sleepiness. Deep, light, and rapid eye movement (REM) sleep durations, mood state, and sports injury severity were exploratory outcomes.
All 25 participants completed the trial. Message delivery success and questionnaire completion were 100% in both groups. Median valid Fitbit wear nights were 26 (IQR 24-28) in the intervention group and 22 (IQR 15-26) in the control group. No major technical problems, adverse events, or privacy breaches occurred. Change in sleep efficiency, the primary preliminary efficacy outcome, favored the intervention group (Hodges-Lehmann between-group difference 2%, 95% CI 0.50%-4%; P=.046; r=0.35). Nominal between-group differences were also observed for the Japanese version of the Pittsburgh Sleep Quality Index (PSQI-J) total score and sleep difficulty score and, among exploratory outcomes, REM sleep duration and total mood disturbance. No between-group differences were observed in TST, WASO, deep or light sleep duration, daytime sleepiness, or sports injury severity.